Release Date: 21/10/14 10:52 Summary: Proposed Company Re-structure Highlights Price Sensitive: Yes Download Document 2.01MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%